HCPLive staff

In part one of our interview with Lea Ann Chen, MD, from NYU Langone Medical Center she discusses the practical aspects of Fecal Microbiota Transplantation.

Rytary, an extended-release oral capsule formulation of carbidopa-levodopa, has been approved for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication and/or manganese intoxication.

A round up of recent research results on plaque psoriasis treatment with itolizumab, apitherapy, and ponesimod.

Cosentyx (secukinumab) has been approved in Japan for the treatment of psoriasis vulgaris (also known as plaque psoriasis) and psoriatic arthritis.

From inflammatory bowel disease to Crohn's disease and everywhere in the gastrointestinal system in between 2014 was a big year for medical breakthroughs and potential future treatments. Here is a look at the top 10 stories.

Obesity and physical activity have become a focus of the healthcare community in the recent past and that was no exception in 2014. Over the past 12 months we have highlighted advancements in the treatment, diagnosis and impact of diabetes on our daily lives. Here is a look at the top 10 stories from the year.

A look at the top rheumatoid arthritis stories on HCPLive for 2014.

Saxenda (liraglutide [rDNA origin] injection) 3 mg has been approved as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in obese and overweight adults who have at least one weight-related comorbidity.

Rapivab (peramivir injection) is an intravenous neuraminidase inhibitor approved for the treatment of acute uncomplicated influenza in patients 18 years and older.

Researchers report that patients diagnosed with moderate to severe plaque psoriasis who were treated with ixekizumab, an investigational anti-interleukin-17A monoclonal antibody, have maintained a favorable clinical response over a year-long course of treatment.

Researchers compared the effectiveness of biologics approved in Europe for the treatment of plaque psoriasis based on their performance as measured by primary endpoints in clinical trials.

Onextron (clindamycin phosphate and benzoyl peroxide), 1.2%/3.75%, has been approved for the once-daily treatment of comedonal and inflammatory acne in patients 12 and older.

Study results show good outcomes for hip replacement in patients under age 35 diagnosed with juvenile idiopathic arthritis who have failed to respond to previous treatment.

Study results show that patients diagnosed with rheumatoid arthritis and who are either significantly underweight or overweight/obese have lower sustained remission rates compared with their normal weight counterparts.

Hysingla ER (hydrocodone bitartrate) is a single-entity oral hydrocodone tablet that is administered to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

Genzyme announced the FDA has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis.

In a surprising move Friday, the Supreme Court agreed to review a closely watched Appeals Court decision that said the federal government can extend tax credits to federally established health exchanges. If the Supreme Court votes to reverse the lower court's decision, it would effectively spell the end of the Affordable Care Act (ACA).

Researchers assessed the effect of seizure status and severity, medication use, mental health indicators, parental support, and other factors on self-reported quality of life in children with epilepsy.

AstraZeneca today announced that the US Food and Drug Administration has approved once-daily Xigduo XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of adults with type 2 diabetes mellitus.

A British company claims it has developed a fast and simple diagnostic test solution specific to the 2014 Ebola outbreak.

A new technique makes it possible to quickly detect the presence of drugs or to monitor certain medical conditions using only a single drop of blood or urine, representing a potential tool for clinicians and law enforcement.

Researchers have found that a simple blood test might help diagnose pancreatic cancer, one of the most deadly forms of the disease.

Research and real-world experience has shown interventions such as constraint therapy, botulinum toxin therapy, and interactive computer play to be effective in children and adolescents with cerebral palsy.

The US Food and Drug Administration (FDA) today announced the approval of Trumenba, the first vaccine licensed in the US to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B.

Data show a significant increase in the prevalence of autism spectrum disorder (ASD) in the US over the last 15 years. More work is needed to identify the genetic and environmental factors associated with increased ASD risk.

Research has shown that comorbid epilepsy and autism spectrum disorder is fairly common, with several factors appearing to influence risk.

Study results presented at CHEST 2014 show that patients with stage I to stage III non-small cell lung cancer have different metabolite profiles in their blood than those of patients who are at risk but do not have lung cancer.

The largest study performed to date of mortality trends in patients with acute respiratory distress syndrome (ARDS) shows that the rate of mortality dropped significantly over a 16-year period.

In remarks delivered at the American Academy of Family Physicians 2014 Assembly, HHS Secretary Sylvia Mathews Burwell spoke about the ongoing response to the Ebola outbreak, improving health care delivery, the Affordable Care Act, and the Transforming Clinical Practice Initiative.

Study results show that eluxadoline may be useful in patients with diarrhea-predominant irritable bowel syndrome (IBS-D) who do not achieve symptom relief with loperamide.